Skip to main content

Fundamentals

Your body is a source of profound information. Each symptom, every shift in energy, and all the subtle changes you perceive are data points in the complex narrative of your health. When you choose to engage with a wellness vendor, you are seeking to translate these feelings into objective metrics, to find a concrete language for your internal state.

This journey often leads to two specific types of biological information ∞ your genetic code and your hormonal profile. Understanding the distinction between them is the first step toward reclaiming your biological sovereignty.

Think of your as the foundational blueprint of a house. It was drafted once, at the moment of your conception, and contains the architectural plans, the material specifications, and the potential for certain features. This blueprint is static; it details predispositions, inherited traits, and the fundamental design of your biological systems.

It reveals probabilities and potentials, such as how efficiently your body might process certain nutrients or your inherited risk for specific conditions. Because this blueprint is permanent and predictive, its protection is a matter of safeguarding your lifelong from misuse.

Your hormonal data, conversely, is a real-time report on the activity within that house. It is a dynamic snapshot of the communication systems, the energy usage, and the environmental responses occurring at this very moment. Hormones are the messengers, the internal emails and directives that regulate everything from your mood and metabolism to your sleep cycles and stress response.

A from a shows your body’s current operational status, reflecting the immediate consequences of your lifestyle, diet, stress levels, and age. This information is fluid, a reflection of your present state of health, and it changes continuously.

Birch bark shedding, revealing layers, symbolizes cellular turnover and tissue regeneration. This reflects physiological adaptation for optimal endocrine balance, promoting metabolic health, foundational wellness, and rejuvenation protocols for patient progress
Intricate, delicate, light-hued fabric with soft folds. Symbolizes the delicate endocrine system and pursuit of hormonal homeostasis

What Is the Core Difference in Data?

The essential distinction lies in what each dataset represents. speaks to unchanging potential. It is a probabilistic map of what could be. Hormonal information speaks to current reality. It is a dynamic dashboard of what is happening right now. This distinction is the very reason the legal frameworks surrounding them have evolved differently.

Legal systems have recognized the unique power and permanence of the genetic blueprint, leading to the creation of specific legislation designed to prevent discrimination based on this immutable code. The law views your DNA as a uniquely sensitive identifier that requires a higher level of protection because it can be used to make predictions about your future health.

Your genetic data is the unchangeable architectural plan of your body, while your hormonal data is the live report of its current activity and communication.

Hormonal data, while deeply personal, is treated by the legal system as a category of clinical health information. Its protections are robust, yet they are part of a broader framework designed to safeguard all medical records. This framework, principally the Portability and Accountability Act (HIPAA), was built to protect the privacy of your current and past health status.

It governs how entities like doctors’ offices and hospitals handle your information. The challenge arises when enter the picture. These direct-to-consumer companies may operate outside the traditional healthcare system, creating potential gaps in the privacy shield you might assume is in place.

Engaging with your own biology through these tests is an act of empowerment. It is a proactive step toward understanding the intricate machinery of your body so you can optimize its function. Part of that empowerment comes from knowing not just what the data says, but also who has access to it and how it is protected.

The journey to personalized wellness requires an understanding of both the biological and the legal landscapes. Your vitality depends on the precise functioning of your endocrine system; your security depends on the integrity of the systems meant to protect your most personal information. Recognizing the different legal weights assigned to your genetic blueprint versus your hormonal status is foundational to navigating this new frontier of health with confidence and control.

The legal protections afforded to your biological data are a direct reflection of how society views the information itself. Genetic data, with its implications for kinship, ancestry, and long-term health risks, has been singled out for special treatment.

The fear that this predictive information could be used by insurers to deny coverage or by employers to block opportunities was a primary motivator for the creation of the (GINA). This law establishes a clear boundary, asserting that your genetic potential should not be used to penalize you in specific contexts.

Textured sphere with smooth core, suspended by stem on striped surface. Represents patient journey to hormonal balance and cellular health
A cracked white spherical shell reveals speckled, perforated spheres surrounding a smooth central orb with radiating filaments. This signifies hormonal imbalance within the endocrine system, highlighting Hormone Replacement Therapy HRT

How Does This Affect Your Wellness Journey?

When you provide a saliva sample for genetic analysis to a wellness company, you are handing over your permanent blueprint. When you submit a blood sample for a hormonal panel, you are providing a snapshot of your current metabolic state. While both are deeply personal, the legal architecture sees them through different lenses.

The protections for your genetic data under are specifically designed to prevent a certain type of discrimination before it happens. The protections for your hormonal data, typically falling under the broader umbrella of health information, are more focused on privacy and preventing unauthorized disclosure.

This creates a complex environment for you, the individual seeking to optimize your health. The wellness vendor you choose becomes a steward of your data. Their privacy policies, their data sharing agreements, and their compliance with various regulations are as much a part of their service as the lab results they provide.

A crucial part of your due diligence is to understand the legal environment in which that vendor operates. Are they a “covered entity” under HIPAA? How do they comply with GINA? What are their policies on de-identifying and selling data for research? These questions are central to ensuring that your quest for wellness does not inadvertently compromise your informational privacy.

Ultimately, the differences in legal protections for genetic and arise from a fundamental distinction in their nature. One is a permanent, predictive blueprint. The other is a dynamic, real-time status report. As you embark on your personal journey of biological discovery, it is essential to appreciate this distinction.

Your power lies not just in the knowledge you gain from the tests themselves, but in understanding the framework that governs how that knowledge is used, shared, and protected. This dual understanding is what allows you to reclaim vitality and function without compromise, fully in control of your health and your data.

Intermediate

Navigating the world of personalized wellness requires a sophisticated understanding of the legal frameworks that govern your biological data. While the fundamental distinction between genetic and hormonal data is clear, the practical application of their legal protections can be complex. The level of security your data receives is highly dependent on the type of organization that holds it.

The two most significant pieces of federal legislation in this domain are the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the Act of 2008 (GINA). Their interplay, and their specific limitations, define the landscape of your data privacy.

Abstract forms depict textured beige structures and a central sphere, symbolizing hormonal dysregulation or perimenopause. Cascading white micronized progesterone spheres and smooth elements represent precise testosterone replacement therapy and peptide protocols, fostering cellular health, metabolic optimization, and endocrine homeostasis
A pristine white sphere, symbolizing optimal cellular health and biochemical balance, is cradled by intricate, textured structures. These represent complex endocrine system pathways and personalized advanced peptide protocols, essential for restoring vitality and achieving metabolic optimization via HRT

HIPAA the Foundation of Health Information Privacy

HIPAA’s Privacy Rule establishes a national standard for the protection of individuals’ medical records and other identifiable health information. It applies to what are known as “covered entities” and their “business associates.”

  • Covered Entities ∞ These are health plans, health care clearinghouses, and health care providers who conduct certain health care transactions electronically. A traditional doctor’s office, a hospital, or your health insurance company are clear examples.
  • Business Associates ∞ These are individuals or organizations that perform work on behalf of a covered entity which involves the use or disclosure of protected health information (PHI). A billing company or a cloud storage service for a hospital would be a business associate.

PHI under is a broad category. It includes any identifiable health information, which certainly covers your hormonal panel results, diagnoses, and treatment plans. The key here is “identifiable.” The information must be linked to you as an individual. HIPAA grants you specific rights, including the right to access your records, request corrections, and know who has seen your information.

It sets limits on how your can be used and disclosed without your explicit authorization. For instance, a hospital cannot sell your health records to a marketing firm.

The critical question for a wellness vendor is whether they qualify as a covered entity. Many direct-to-consumer (DTC) wellness companies do not. If you pay a company out-of-pocket for a hormone test and they do not bill an insurance company on your behalf, they may fall outside of HIPAA’s jurisdiction.

In such cases, their handling of your data is governed by their own terms of service and privacy policy, as well as broader consumer protection laws like the Federal Trade Commission (FTC) Act, which prohibits unfair and deceptive practices.

A luminous core sphere, symbolizing optimized cellular health and reclaimed vitality, is encircled by textured elements representing targeted peptide protocols. Intricate lattice structures depict the complex endocrine system and personalized medicine frameworks, while halved figs suggest metabolic balance and comprehensive hormone optimization for clinical wellness
Dynamic white fluid, representing hormone optimization and cellular signaling, interacts with a structured sphere, symbolizing target organs for bioidentical hormones. A bone element suggests skeletal integrity concerns in menopause or andropause, emphasizing HRT for homeostasis

GINA the Genetic Shield

The passage of GINA was a landmark event. Lawmakers recognized that genetic information was unique because of its predictive power and its permanence. GINA was designed to allay public fears that genetic testing could lead to discrimination, thereby encouraging people to participate in research and proactive health screening. GINA’s protections are divided into two main parts:

  • Title I ∞ Prohibits health insurance companies from using genetic information to make decisions about eligibility, coverage, or premiums. An insurer cannot require you to take a genetic test, nor can they use your family history or the results of a genetic test to set your rates.
  • Title II ∞ Prohibits employers (with 15 or more employees) from using genetic information in decisions about hiring, firing, promotion, or any other terms of employment.

GINA defines “genetic information” broadly. It includes not only the results of your genetic tests but also the genetic tests of your family members and your family medical history. It even covers requests for and receipt of genetic services. This creates a strong shield in the specific domains of health insurance and employment.

The legal protections for your health data are not monolithic; they are a mosaic of laws where HIPAA provides a broad base for clinical information and GINA adds a specific, powerful shield for your genetic code.

However, GINA’s shield has well-defined limits. It does not apply to life insurance, disability insurance, or long-term care insurance. This is a significant gap. An insurer for one of these products could potentially ask for your genetic information or use it in their underwriting decisions.

Furthermore, GINA’s protections cease once a genetic predisposition “manifests” as a diagnosable condition. For example, GINA would protect you based on a genetic marker for hemochromatosis. Once you are diagnosed with the disease itself, that diagnosis becomes part of your health record. While GINA still protects the underlying genetic information, the condition itself can be used by certain insurers, like disability or life insurers, in their decision-making process.

A macroscopic rendering of intricate cellular structures, one sphere revealing a smooth, luminous core. This visually encapsulates the precision of bioidentical hormone replacement therapy, addressing hormonal imbalance by restoring cellular homeostasis
A woman's calm interaction with a Siamese cat by a window portrays profound patient well-being. This serene moment signifies physiological harmony and emotional regulation, key outcomes of effective hormone optimization

Comparing the Legal Shields

The differences in how these laws treat your data are stark. A side-by-side comparison reveals the nuanced reality of your data’s legal standing, especially when dealing with a wellness vendor who may not be a HIPAA-covered entity.

Legal Protection Framework Comparison
Feature HIPAA (for Hormonal & Other Health Data) GINA (for Genetic Data)
Primary Purpose Privacy and security of all Protected Health Information (PHI). Prevent discrimination based on genetic information in health insurance and employment.
Who It Applies To “Covered Entities” (Health Plans, Providers, Clearinghouses) and their “Business Associates.” May not apply to many DTC wellness vendors. Health insurers, group health plans, and employers with 15 or more employees.
What Is Protected All individually identifiable health information, including hormonal data, diagnoses, and treatments. Genetic test results, family medical history, and use of genetic services.
Key Prohibition Prohibits unauthorized use and disclosure of PHI. Prohibits use of genetic information for underwriting (health insurance) or employment decisions.
Major Gaps Does not cover many DTC wellness companies. Data held by them is governed by consumer protection laws and their own privacy policies. Does not apply to life insurance, disability insurance, or long-term care insurance. Does not protect against discrimination based on a manifested disease.
A vibrant green leaf with multiple perforations and a desiccated, pale leaf rest upon a supportive white mesh. This symbolizes the progression from initial hormonal imbalance and cellular degradation to the restoration of endocrine resilience through precise bioidentical hormone therapy
Cracks on this spherical object symbolize hormonal dysregulation and cellular degradation. They reflect the delicate biochemical balance within the endocrine system, highlighting the critical need for personalized HRT protocols to restore homeostasis for hypogonadism and menopause

What Is the Practical Implication for You?

Imagine you use a wellness vendor for both a genetic test and a series of hormone panels. The vendor is a DTC company and does not bill insurance, so it is not a HIPAA-covered entity. Your protection rests on a different set of rules.

  1. Your Genetic Data ∞ GINA’s protections still apply to how health insurers and employers can use this data, regardless of where they get it from. If your health insurer somehow obtained your genetic data from this wellness vendor, they would be prohibited by GINA from raising your premiums. Similarly, your employer could not fire you based on that information. The wellness vendor itself, however, is primarily bound by its privacy policy regarding what it can do with your data (e.g. sell de-identified data for research).
  2. Your Hormonal Data ∞ This information has fewer specific federal protections in this context. Because the vendor is not a HIPAA entity, the handling of your testosterone, estrogen, or cortisol levels is governed by the contract you agreed to ∞ their terms of service. State-level privacy laws, like the California Consumer Privacy Act (CCPA), may grant you additional rights, such as the right to know what data is collected and to have it deleted. The primary federal oversight comes from the FTC, which can take action if the company uses your data in a way that is unfair or deceptive, or contradicts its own privacy policy.

This creates a tiered system of protection. Your genetic data has a federal shield against specific types of discrimination, while your hormonal data’s privacy is more dependent on the vendor’s promises and state-level consumer rights. Understanding this distinction is paramount.

It means that reading the of a wellness vendor is not a mere formality; it is a critical step in understanding the legal agreement you are making about the stewardship of your most personal biological information. Your journey toward optimized health is deeply intertwined with this complex legal fabric, and navigating it successfully requires both biological literacy and legal awareness.

Academic

The bifurcated legal framework governing genetic and hormonal data in the United States represents more than a simple legislative distinction; it is the codification of a specific, and increasingly outdated, philosophy of biological identity. This framework, anchored by the Health Insurance Portability and Accountability Act (HIPAA) and the Genetic Information Nondiscrimination Act (GINA), establishes a hierarchy of biological information.

It elevates the genetic code to a special status, viewing it as a permanent and predictive “master text,” while categorizing hormonal data as part of the body’s transient, functional narrative. This legal dichotomy, while well-intentioned, fails to account for the systemic, interconnected nature of human biology revealed by modern endocrinology and systems biology.

It creates a precarious gap in protection, particularly within the burgeoning direct-to-consumer (DTC) wellness market, and raises profound questions about the nature of privacy and identity in an era of ubiquitous self-quantification.

An abstract visual depicts hormonal imbalance speckled spheres transforming into cellular health. A molecular stream, representing advanced peptide protocols and bioidentical hormone therapy, promotes cellular repair, metabolic optimization, and biochemical balance
Two structured, silvery forms emerge from a natural root, embodying precise Hormone Optimization and Biochemical Balance. They represent Advanced Peptide Protocols and Bioidentical Hormones for Hormone Replacement Therapy, addressing Hypogonadism or Menopause, restoring Homeostasis and Reclaimed Vitality

The Ontological Error in Legal Frameworks

The legal architecture of privacy is built upon an ontological assumption that separates the blueprint from the building. GINA was enacted to protect the genetic blueprint ∞ the DNA sequence ∞ from being used to create discriminatory social and economic structures.

Its passage was a victory for civil rights, premised on the idea that an individual’s immutable, probabilistic future should not be a basis for present-day penalty. The law’s focus on genetic information as a unique category of data is a direct response to the concept of “genetic determinism” ∞ the notion that genes are destiny. By carving out specific protections for this information, the law sought to neutralize its power in the hands of insurers and employers.

Hormonal data, in contrast, is legally situated within the broader category of “Protected Health Information” (PHI) under HIPAA. This data, which includes levels of testosterone, estradiol, cortisol, thyroid-stimulating hormone, and other signaling molecules, is treated as a reflection of a “manifested” state. It is a record of the body’s current physiological function.

From a legal perspective, it is a clinical data point, akin to blood pressure or cholesterol levels. It describes what is, rather than what might be. Therefore, its primary legal protection is one of privacy (controlling its disclosure) rather than non-discrimination in the specific manner GINA outlines.

This legal distinction, however, is a profound oversimplification of biological reality. Modern endocrinology understands that the endocrine system is a complex, adaptive network. Hormonal expression is the very mechanism through which the genetic blueprint is translated into physiological reality, constantly modulated by environmental inputs.

The Hypothalamic-Pituitary-Gonadal (HPG) axis, for example, is a dynamic feedback loop where genetic predispositions and external stressors are integrated to produce a specific hormonal milieu. This milieu, in turn, influences gene expression itself through epigenetic modifications. The relationship between genes and hormones is not linear and unidirectional; it is a continuous, recursive dialogue.

Therefore, to treat genetic data as uniquely predictive while treating hormonal data as merely descriptive is a scientific fallacy. A comprehensive hormonal panel, particularly when tracked over time, can be profoundly predictive.

It can reveal the trajectory of metabolic disease, the onset of menopause, the decline of and-rogenic function, or the physiological toll of chronic stress with a much higher degree of certainty and immediacy than many single-gene polymorphisms. The law, in its attempt to isolate the “genetic,” has failed to appreciate the informational richness and predictive power of the “hormonal.”

An air plant displays distinct, spherical pods. This represents the meticulous approach of Hormone Replacement Therapy to achieve Hormonal Balance
A white tulip-like bloom reveals its intricate core. Six textured, greyish anther-like structures encircle a smooth, white central pistil

The Wellness Vendor a Jurisdictional Void?

This philosophical flaw in the legal framework has significant practical consequences, especially in the context of DTC wellness vendors. These companies often exist in a jurisdictional gray area, potentially outside the direct oversight of HIPAA.

A company that provides a hormonal analysis or a genetic test without accepting health insurance or acting on behalf of a is generally not a “covered entity” itself. Consequently, the vast trove of PHI they collect, including deeply sensitive hormonal data, is not subject to HIPAA’s stringent privacy and security rules.

In this scenario, the user’s primary protection for their hormonal data is the vendor’s privacy policy, a contract of adhesion, and the oversight of the Federal Trade Commission (FTC). The FTC’s authority is largely limited to ensuring companies do not engage in “unfair or deceptive” practices. This means they can hold a company accountable for violating its own stated privacy policy, but they cannot impose a HIPAA-like standard of care on the data itself.

The current legal framework creates an artificial distinction between genetic and hormonal data, a separation that ignores their deep biological interconnectedness and leaves dynamic health information vulnerable.

The protections for genetic data are somewhat more robust, yet still incomplete. GINA’s prohibitions on health insurers and employers using genetic information apply regardless of how they obtain the information. This means that even if the data comes from a non-HIPAA-covered wellness vendor, its use in those specific contexts is still restricted.

However, this protection is narrowly tailored. It does not prevent the wellness vendor from using the data for other purposes, such as selling de-identified or aggregated data to pharmaceutical companies or research institutions, as long as this is permitted by their privacy policy.

This creates a paradoxical situation. A wellness vendor could potentially handle a user’s sensitive hormonal data with fewer legal constraints than a traditional hospital, while at the same time collecting a vast database of genetic information that is only protected against a narrow set of discriminatory uses. The following table illustrates the nuanced vulnerabilities that arise from this regulatory gap.

Data Vulnerability Analysis In DTC Wellness Context
Data Type & Scenario Applicable Law Key Vulnerability
Hormonal Data (e.g. Testosterone, Estradiol levels) held by a non-HIPAA DTC vendor. Vendor Privacy Policy, FTC Act, State Consumer Privacy Laws (e.g. CCPA). Lack of a federal privacy standard. Data can be used for internal marketing, sold in aggregated form, and is vulnerable to security breaches with less stringent reporting requirements than HIPAA.
Genetic Data (e.g. SNP analysis) held by a non-HIPAA DTC vendor. GINA, Vendor Privacy Policy, FTC Act, State Consumer Privacy Laws. GINA’s protections are specific to health insurance and employment. The data is not protected from use by life, disability, or long-term care insurers. The vendor can still commercialize the data in ways permitted by its policy.
Combined Analysis (e.g. Using hormonal data to interpret genetic risk for metabolic syndrome). A complex interplay of all the above. The synthesis of these two data types creates a highly predictive model of current and future health that is not adequately contemplated by the siloed legal frameworks. This “inferred” data may fall through the cracks of existing definitions.
A metallic pleated form supports a central sphere cluster, representing precise hormone optimization and bioidentical hormone therapy. An intricate lattice symbolizes cellular matrix supporting endocrine homeostasis
A composite sphere, half brain-like and half intricate florets, symbolizes neuroendocrine regulation and cellular function. This visual metaphor underscores hormone optimization, metabolic health, endocrine balance, and patient outcomes through precision medicine and wellness protocols

The Future of Biological Privacy a Systems Approach

The current legal paradigm is untenable in the face of advancing biomedical science. The increasing sophistication of wearable sensors, continuous glucose monitors, and advanced hormonal testing is blurring the line between “descriptive” and “predictive” data. A continuous stream of data on heart rate variability, sleep architecture, and glucose response is, in aggregate, a powerful predictor of future health outcomes. This data, like hormonal data, largely falls outside the specific protections of GINA and often outside the jurisdiction of HIPAA.

A new legal and ethical framework is required, one that moves beyond the genetic blueprint/manifested state dichotomy. Such a framework would need to adopt a systems-biology perspective, recognizing that all biological data points are interconnected and contribute to a holistic picture of an individual’s health.

It would need to be based on the sensitivity and predictive power of the data itself, rather than on its source (genes vs. hormones) or the entity holding it (a hospital vs. a wellness app).

Potential elements of such a framework could include:

  1. A Tiered Data-Sensitivity Model ∞ Instead of a binary system, data could be classified based on its potential for misuse. Tier 1 might be de-identified usage data, while Tier 3 could be personally identifiable, predictive health information, regardless of its origin, with the highest level of protection.
  2. Expanded Non-Discrimination Protections ∞ The principles of GINA could be extended to cover other forms of predictive health data, including longitudinal hormonal data, and apply to a broader range of products, such as life and disability insurance.
  3. A Unified Federal Privacy Law ∞ A comprehensive federal privacy law, similar to Europe’s GDPR, could harmonize the patchwork of state laws and extend HIPAA-like protections to all entities that handle sensitive health information, including DTC wellness companies.

The distinction in legal protections for genetic and hormonal data is a relic of a past scientific and legal era. It creates a false sense of security and leaves the modern wellness consumer navigating a treacherous landscape of privacy policies and regulatory gaps.

The path forward requires a legal framework that is as sophisticated and interconnected as the biological systems it seeks to protect. Until then, the responsibility falls upon the individual to be not only the steward of their own health but also the diligent guardian of their own biological information, armed with a deep understanding of the limitations of the laws designed to protect them.

Four symmetrical buildings, viewed from below, symbolize robust clinical pathways for hormone optimization. This foundational structure supports personalized treatment for metabolic health, driving therapeutic efficacy, cellular function enhancement, and optimal patient outcomes through biomarker analysis
A detailed microscopic depiction of a white core, possibly a bioidentical hormone, enveloped by textured green spheres representing specific cellular receptors. Intricate mesh structures and background tissue elements symbolize the endocrine system's precise modulation for hormone optimization, supporting metabolic homeostasis and cellular regeneration in personalized HRT protocols

References

  • U.S. Department of Health and Human Services. “Genetic Information.” HHS.gov, 16 June 2017.
  • U.S. Department of Labor. “FAQs Regarding the Genetic Information Nondiscrimination Act.” DOL.gov.
  • Municipal Technical Advisory Service. “Human Resources | GINA and HIPAA, Employment, Genetic Information.” MTAS.tennessee.edu, 21 Oct. 2022.
  • Ally, Farrah; Ayannuga, Olufunke; and Michie, Marsha. “Genetic Information, Non-Discrimination, and Privacy Protections in Genetic Counseling Practice.” Journal of Genetic Counseling, vol. 23, no. 5, 2014, pp. 783-87.
  • American Society of Human Genetics. “The Genetic Information Nondiscrimination Act (GINA).” ASHG.org.

Reflection

What Does Your Data Truly Represent?

You began this inquiry seeking to understand your body on a deeper level. The data points from a genetic test or a hormonal panel are compelling; they provide a language for the complex interplay of systems that constitute your physical self.

You have now seen that this data also has a second life as a legal and commercial asset, governed by a complex and imperfect set of rules. The knowledge you have gained about these protections is as vital as any lab result.

This understanding shifts your role. You are the curator of your own biological story. Each data point you choose to generate adds a new sentence to that narrative. The core question now becomes one of intention. Why are you seeking this information? What do you hope to achieve with it? Is it to address a specific symptom, to optimize performance, or simply to satisfy a deep-seated curiosity about the inner workings of your own being?

The path to true wellness is paved with this kind of informed intention. It requires you to hold both the scientific and the legal realities in your mind at once. It asks you to weigh the profound benefits of personalized health insights against the tangible risks of data vulnerability.

This is the new frontier of personal responsibility in health. The answers are not in the data alone; they are in the wisdom you apply to its acquisition, interpretation, and protection. Your journey forward is defined by the choices you make with this dual awareness.